#USA #New York #Pomerantz #SelectQuote #SLQT

Investor Alert: SelectQuote Class Action

The Pomerantz Law Firm has recently announced a class action lawsuit against SelectQuote, Inc., trading under the ticker SLQT on the NYSE. This lawsuit comes as a direct response to allegations concerning securities fraud and questionable business practices wrapped around the company's dealings from 2016 to 2021.

Background of the Case

On August 22, 2025, Pomerantz LLP stated that investors who suffered financial losses while investing in SelectQuote are urged to reach out to the firm. They can contact Danielle Peyton via email or phone for more information. Potential class members have until October 10, 2025, to petition the Court to appoint them as Lead Plaintiff in this litigation. Interested parties are encouraged to provide their contact details, including mailing address, phone number, and the number of shares they purchased.

The central issue leading to this lawsuit stems from the allegations made by the U.S. Department of Justice (DOJ) in a complaint filed on May 1, 2025. The DOJ has indicated that SelectQuote was in receipt of illegal kickbacks from health insurance firms in return for directing Medicare beneficiaries toward certain insurance plans. Furthermore, it claimed that the company conspired with major insurers to unjustly discriminate against beneficiaries considered less profitable, such as those with disabilities.

As the DOJ describes, SelectQuote misrepresented itself by promoting impartial coverage comparisons. Rather, it consistently nudged Medicare beneficiaries towards plans that were most financially beneficial for the company rather than focusing on the quality of options available to the beneficiaries. This behavior, according to the DOJ, led to materially false claims, significantly damaging the trust and financial well-being of investments from affected parties.

Impact of the Allegations

The financial ramifications for SelectQuote were immediate and severe. Following the announcement of the DOJ's lawsuit, shares of SelectQuote plunged by $0.61, marking a staggering decrease of 19.24% to finish at $2.56 per share. This sharp decline serves as a significant indicator of how investor confidence can be shaken by litigation surrounding accusations of fraud and misconduct.

About Pomerantz Law Firm

Pomerantz LLP is renowned for its dedication to protecting the rights of investors and its leadership in class action litigation related to securities, antitrust, and corporate governance issues. Founded more than eight decades ago by Abraham L. Pomerantz, the firm has recovered hundreds of millions in damages for its clients. Their example of commitment to justice and corporate accountability has established them as a prominent figure in this sector.

Informed participation in this class action lawsuit could potentially lead to compensatory damages for investors adversely affected by SelectQuote's actions. For detailed information about the class action and how to engage, investors are encouraged to visit Pomerantz Law Firm's website.

Conclusion

Investors in SelectQuote must remain vigilant. As the class action unfolds, the implications of corporate accountability in the case of alleged fraud, particularly within the healthcare landscape, could have broader ramifications for similar companies in the industry. By staying informed and involved, affected investors can play an active role in seeking justice and potentially recouping some of their losses. Make sure to act promptly, as deadlines are approaching and time is of the essence.